Advertisement
U.S. Markets closed
S&P Futures
5,909.25 +3.25 (+0.06%) Dow Futures
43,548.00 +30.00 (+0.07%) Nasdaq Futures
20,490.25 +6.75 (+0.03%) Russell 2000 Futures
2,294.80 +3.60 (+0.16%) Crude Oil
69.59 +0.37 (+0.53%) Gold
2,746.70 +16.70 (+0.61%)
Satellos Bioscience Inc. (MSCLF)
OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
Follow
At close: 04:00PM EDT
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 65.74M |
| Enterprise Value | 31.93M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.00 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 4.75 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.00 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 0.6183 |
| 52 Week Low 3 | 0.2200 |
| 50-Day Moving Average 3 | 0.3881 |
| 200-Day Moving Average 3 | 0.3868 |
Share Statistics
| Avg Vol (3 month) 3 | 12.37k |
| Avg Vol (10 day) 3 | 15.72k |
| Shares Outstanding 5 | 113.38M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 87.63M |
| % Held by Insiders 1 | 12.40% |
| % Held by Institutions 1 | 6.19% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Currency in CAD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -37.20% |
| Return on Equity (ttm) | -58.84% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -25.66M |
| Net Income Avi to Common (ttm) | -23.05M |
| Diluted EPS (ttm) | -0.1400 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 27.7M |
| Total Cash Per Share (mrq) | 0.25 |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.26 |
| Book Value Per Share (mrq) | 0.26 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22.23M |
| Levered Free Cash Flow (ttm) | -11.98M |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.